Tracy Chad R, Costabile Raymond A
Department of Urology, University of Virginia School of Medicine, Box 800422, Charlottesville, VA 22908, USA.
World J Urol. 2009 Apr;27(2):259-63. doi: 10.1007/s00345-008-0338-0. Epub 2008 Nov 12.
To review the evaluation and treatment of epididymitis in a contemporary population and evaluate adherence to Centers for Disease Control (CDC) guidelines.
From 1999 to 2005, 870 patients from a single institution were diagnosed with epididymitis. Information regarding patient demographics, diagnostic evaluation, and treatment was reviewed. Adherence to CDC guidelines for the treatment of acute epididymitis was evaluated.
A total of 455 men between 3 and 88 years met inclusion requirements for acute epididymitis. Seven percent of pediatric patients (< 18 years) and 29.5% of adult patients (> or = 18 years) undergoing urine culture demonstrated bacterial growth. Twelve percent of adult patients with urethral swab PCR performed for Chlamydia trachomatis had positive results. A bacterial etiology for epididymitis was documented in 6.6% of pediatric patients and 28% of adult patients who were tested by urine culture and/or urethral swab for C. trachomatis. Less than 35% of adult men underwent the appropriate CDC work-up. Fifty percent of patients, 18-35 years and 85% of patients, > 35 years were prescribed an effective treatment according to CDC guidelines. Patients were less likely to be admitted to the hospital (100 vs. 2.3%) and more likely to be treated with antibiotics than in previously published series (97 vs. 75%).
CDC guidelines for the evaluation and treatment of acute epididymitis were followed in less than 35% of patients seen in a university based health care system. Despite a paucity of documented urinary infection, 97% of adult men are treated empirically with antibiotics often not in accordance with CDC guidelines.
回顾当代人群附睾炎的评估与治疗情况,并评估对疾病控制中心(CDC)指南的遵循情况。
1999年至2005年,来自单一机构的870例患者被诊断为附睾炎。回顾了有关患者人口统计学、诊断评估和治疗的信息。评估了对CDC急性附睾炎治疗指南的遵循情况。
共有455名年龄在3至88岁之间的男性符合急性附睾炎的纳入标准。接受尿培养的儿科患者(<18岁)中有7%以及成年患者(≥18岁)中有29.5%显示有细菌生长。对沙眼衣原体进行尿道拭子PCR检测的成年患者中有12%结果呈阳性。通过尿培养和/或尿道拭子检测沙眼衣原体的儿科患者中有6.6%、成年患者中有28%记录到附睾炎的细菌病因。不到35%的成年男性接受了适当的CDC检查。根据CDC指南,18至35岁的患者中有50%、>35岁的患者中有85%接受了有效治疗。与先前发表的系列研究相比,患者住院的可能性较小(100比2.3%),接受抗生素治疗的可能性较大(97比75%)。
在一个大学附属医疗系统中,不到35%的患者遵循了CDC急性附睾炎评估和治疗指南。尽管记录在案的泌尿系统感染较少,但97%的成年男性通常未按照CDC指南接受经验性抗生素治疗。